These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
403 related articles for article (PubMed ID: 32402723)
1. Safety of direct oral anticoagulant - and antiplatelet therapy in patients with atrial fibrillation treated by carotid artery stenting. Nii K; Takemura Y; Inoue R; Morinaga Y; Mitsutake T; Higashi T J Stroke Cerebrovasc Dis; 2020 Jul; 29(7):104899. PubMed ID: 32402723 [TBL] [Abstract][Full Text] [Related]
2. Concomitant use of direct oral anticoagulants and aspirin versus direct oral anticoagulants alone in atrial fibrillation and flutter: a retrospective cohort. Said A; Keeney S; Matka M; Hafeez A; George J; Halalau A BMC Cardiovasc Disord; 2020 Jun; 20(1):263. PubMed ID: 32487114 [TBL] [Abstract][Full Text] [Related]
3. Novel Oral Anticoagulant Based Versus Vitamin K Antagonist Based Double Therapy Among Stented Patients With Atrial Fibrillation: Insights From the PIONEER AF-PCI Trial. Kerneis M; Yee MK; Mehran R; Nafee T; Bode C; Halperin JL; Peterson ED; Verheugt FWA; Wildgoose P; van Eickels M; Lip GYH; Cohen M; Fox KAA; Gibson CM Circ Cardiovasc Interv; 2019 Nov; 12(11):e008160. PubMed ID: 31707805 [TBL] [Abstract][Full Text] [Related]
4. Thromboembolic, bleeding, and mortality risks among patients with nonvalvular atrial fibrillation treated with dual antiplatelet therapy versus oral anticoagulants: A population-based study. Lau WCY; Douglas IJ; Wong ICK; Smeeth L; Lip GYH; Leung WK; Siu CW; Cheung BMY; Mok MTC; Chan EW Heart Rhythm; 2020 Jan; 17(1):33-40. PubMed ID: 31377423 [TBL] [Abstract][Full Text] [Related]
5. Effect of Procedure and Coronary Lesion Characteristics on Clinical Outcomes Among Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention: Insights From the PIONEER AF-PCI Trial. Kerneis M; Gibson CM; Chi G; Mehran R; AlKhalfan F; Talib U; Pahlavani S; Mir M; Bode C; Halperin JL; Nafee T; Peterson ED; Verheugt FWA; Wildgoose P; van Eickels M; Lip GYH; Fox KAA; Cohen M JACC Cardiovasc Interv; 2018 Apr; 11(7):626-634. PubMed ID: 29550085 [TBL] [Abstract][Full Text] [Related]
6. Effect of Lesion Complexity and Clinical Risk Factors on the Efficacy and Safety of Dabigatran Dual Therapy Versus Warfarin Triple Therapy in Atrial Fibrillation After Percutaneous Coronary Intervention: A Subgroup Analysis From the REDUAL PCI Trial. Berry NC; Mauri L; Steg PG; Bhatt DL; Hohnloser SH; Nordaby M; Miede C; Kimura T; Lip GYH; Oldgren J; Ten Berg JM; Cannon CP Circ Cardiovasc Interv; 2020 Apr; 13(4):e008349. PubMed ID: 32252548 [TBL] [Abstract][Full Text] [Related]
7. Propensity-Matched Comparison of Oral Anticoagulation Versus Antiplatelet Therapy After Left Atrial Appendage Closure With WATCHMAN. Søndergaard L; Wong YH; Reddy VY; Boersma LVA; Bergmann MW; Doshi S; Kar S; Sievert H; Wehrenberg S; Stein K; Holmes DR JACC Cardiovasc Interv; 2019 Jun; 12(11):1055-1063. PubMed ID: 31171282 [TBL] [Abstract][Full Text] [Related]
8. Use of Dual Antiplatelet Therapy and Patient Outcomes in Those Undergoing Percutaneous Coronary Intervention: The ROCKET AF Trial. Sherwood MW; Cyr DD; Jones WS; Becker RC; Berkowitz SD; Washam JB; Breithardt G; Fox KA; Halperin JL; Hankey GJ; Singer DE; Piccini JP; Nessel CC; Mahaffey KW; Patel MR JACC Cardiovasc Interv; 2016 Aug; 9(16):1694-702. PubMed ID: 27539689 [TBL] [Abstract][Full Text] [Related]
9. Thromboembolic Risk, Bleeding Outcomes and Effect of Different Antithrombotic Strategies in Very Elderly Patients With Atrial Fibrillation: A Sub-Analysis From the PREFER in AF ( Patti G; Lucerna M; Pecen L; Siller-Matula JM; Cavallari I; Kirchhof P; De Caterina R J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28736385 [TBL] [Abstract][Full Text] [Related]
10. Antithrombotic therapy in patients with atrial fibrillation undergoing coronary artery stenting. Lacoste JL; Hansen CL Am J Health Syst Pharm; 2019 Sep; 76(18):1395-1402. PubMed ID: 31505555 [TBL] [Abstract][Full Text] [Related]
11. Antiplatelet therapy for stable coronary artery disease in atrial fibrillation patients taking an oral anticoagulant: a nationwide cohort study. Lamberts M; Gislason GH; Lip GY; Lassen JF; Olesen JB; Mikkelsen AP; Sørensen R; Køber L; Torp-Pedersen C; Hansen ML Circulation; 2014 Apr; 129(15):1577-85. PubMed ID: 24470482 [TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of percutaneous left atrial appendage closure to prevent thromboembolic events in atrial fibrillation patients with high stroke and bleeding risk. Seeger J; Bothner C; Dahme T; Gonska B; Scharnbeck D; Markovic S; Rottbauer W; Wöhrle J Clin Res Cardiol; 2016 Mar; 105(3):225-9. PubMed ID: 26318322 [TBL] [Abstract][Full Text] [Related]
13. Dual antiplatelet therapy versus oral anticoagulation plus dual antiplatelet therapy in patients with atrial fibrillation and low-to-moderate thromboembolic risk undergoing coronary stenting: design of the MUSICA-2 randomized trial. Sambola A; Montoro JB; Del Blanco BG; Llavero N; Barrabés JA; Alfonso F; Bueno H; Cequier A; Serra A; Zueco J; Sabaté M; Rodríguez-Leor O; García-Dorado D Am Heart J; 2013 Oct; 166(4):669-75. PubMed ID: 24093846 [TBL] [Abstract][Full Text] [Related]
14. Outcomes of endovascular venous stenting in patients on direct oral anticoagulants and antiplatelet therapy at a tertiary referral center. Hays K; Jolly M; Silver M; Phillips J; Huff C; Secic M; Ansel G; Kolluri R J Vasc Surg Venous Lymphat Disord; 2021 May; 9(3):753-759.e1. PubMed ID: 32827732 [TBL] [Abstract][Full Text] [Related]
15. Eptifibatide use following emergent carotid stenting in acute anterior circulation ischemic stroke with tandem occlusion. Osteraas ND; Crowley RW; Panos N; Dafer RM J Stroke Cerebrovasc Dis; 2020 Sep; 29(9):105021. PubMed ID: 32807436 [TBL] [Abstract][Full Text] [Related]